Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is the Immune System?01:38

What is the Immune System?

127.5K
Overview
127.5K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.0K
Overview
80.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.0K
Overview
84.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

8.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.8K
Humoral Immune Responses01:36

Humoral Immune Responses

83.8K
Overview
83.8K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

9.2K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MHC Attention: Identifying HLA-E presented cancer antigens through deep learning and high-throughput screening.

bioRxiv : the preprint server for biology·2026
Same author

Antitumor efficacy and safety of locoregional [<sup>177</sup>Lu]Lu-RM26 radionuclide therapy in glioblastoma.

European journal of nuclear medicine and molecular imaging·2026
Same author

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Blood·2026
Same author

The Double-Edged Sword: How Radiotherapy Shapes the Tumor Immune Microenvironment to Modulate Responses to Checkpoint Inhibitors.

International journal of molecular sciences·2026
Same author

Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients.

Journal of neuro-oncology·2026

Related Experiment Video

Updated: Jan 27, 2026

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
08:34

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment

Published on: March 2, 2016

10.1K

Engineered immune cells as highly sensitive cancer diagnostics.

Amin Aalipour1,2, Hui-Yen Chuang2,3, Surya Murty1,2

  • 1Department of Bioengineering, Stanford University School of Medicine, Stanford, CA, USA.

Nature Biotechnology
|March 20, 2019
PubMed
Summary

Researchers developed a novel macrophage-based sensor for highly sensitive early cancer detection. This innovative approach uses engineered macrophages to identify tumors as small as 25 mm³ via blood analysis, outperforming current biomarkers.

More Related Videos

A Sensitive Method to Quantify Senescent Cancer Cells
09:18

A Sensitive Method to Quantify Senescent Cancer Cells

Published on: August 2, 2013

21.2K
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.8K

Related Experiment Videos

Last Updated: Jan 27, 2026

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
08:34

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment

Published on: March 2, 2016

10.1K
A Sensitive Method to Quantify Senescent Cancer Cells
09:18

A Sensitive Method to Quantify Senescent Cancer Cells

Published on: August 2, 2013

21.2K
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.8K

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Immunology

Background:

  • Endogenous biomarkers are crucial for early disease detection but often lack sufficient sensitivity and specificity.
  • Current diagnostic methods face challenges in early and accurate cancer identification.

Purpose of the Study:

  • To develop a highly sensitive, cell-based in vivo sensor for early cancer detection.
  • To engineer macrophages as reporters for tumor-associated metabolic profiles.

Main Methods:

  • Macrophages were engineered to express luciferase under the control of the arginase-1 promoter.
  • Engineered macrophages were adoptively transferred into mouse models of colorectal and breast cancer.
  • Bioluminescence imaging and blood luciferase measurements were used for detection.

Main Results:

  • The engineered macrophage sensor detected small tumors (25-50 mm³) in vivo.
  • The sensor demonstrated high sensitivity, surpassing existing protein and nucleic acid biomarkers.
  • The system effectively monitored inflammatory responses in non-cancerous models.

Conclusions:

  • Engineered macrophages serve as a sensitive and specific in vivo sensor for early cancer detection.
  • This cell-based sensor technology holds promise for improved disease monitoring beyond cancer.